Dejerine–Roussy syndrome
Dejerine–Roussy syndrome | |
---|---|
Other names | Thalamic pain syndrome |
Specialty | Neurology |
Dejerine–Roussy syndrome or thalamic pain syndrome is a condition developed after a thalamic
Symptoms and signs
Dejerine–Roussy syndrome is most commonly preceded by numbness in the affected side. In these cases, numbness is replaced by burning and tingling sensations, widely varying in degree of severity across all cases.
Allodynia is pain from a stimulus that would normally not cause pain.[4][5] For example, there is a patient who experiences unrelenting pain when a breeze touches his skin. Most patients experiencing allodynia, experience pain with touch and pressure, however some can be hypersensitive to temperature.[medical citation needed]
Allodynia and dysaesthesia replace numbness between one week and a few months after a thalamic stroke. In general, once the development of pain has stopped, the type and severity of pain will be unchanging and if untreated, persist throughout life. Consequentially, many will undergo some form of pain treatment and adjust to their new lives as best they can.[medical citation needed]
Pain associated with Dejerine–Roussy syndrome is sometimes coupled with anosognosia or somatoparaphrenia which causes a patient having undergone a right-parietal, or right-sided stroke to deny any paralysis of the left side when indeed there is, or deny the paralyzed limb(s) belong to them. Although debatable, these symptoms are rare and considered part of a "thalamic phenomenon", and are not normally considered a characteristic of Dejerine–Roussy syndrome.[medical citation needed]
Mechanism
Although there are many contributing factors and risks associated with strokes, there are very few associated with Dejerine–Roussy syndrome and thalamic lesions specifically. In general, strokes damage one hemisphere of the brain, which can include the
Recently, magnetic resonance imaging has been utilized to correlate lesion size and location with area affected and severity of condition. Although preliminary, these findings hold promise for an objective way to understand and treat patients with Dejerine–Roussy syndrome.[7]
Diagnosis
Dejerine-Roussy is a rare pain syndrome. Individuals with emerging Dejerine–Roussy syndrome usually report they are experiencing unusual pain or sensitivity that can be allodynic in nature or triggered by seemingly unrelated stimuli (sounds, tastes). Symptoms are typically lateralized and may include vision loss or loss of balance (position sense). Workup should be performed by a neurologist and brain imaging to look for evidence of infarction or tumor should be obtained.[citation needed]
Treatments
Many chemical medications have been used for a broad range of
The most common treatment plans involve a schedule of physical therapy with a medication regimen. Because the pain is mostly unchanging after development, many patients test different medications and eventually choose the regimen that best adapts to their lifestyle, the most common of which are orally and intravenously administered.[medical citation needed]
Pharmaceutical treatment
- Opiates contain the narcotics sweating.[8][unreliable medical source?]
- Anti-depressants are traditionally administered for treatment of mood disorders, also linked to the thalamus, and can be used to treat Dejerine–Roussy symptoms. Specifically, tricyclic anti-depressants such as amitriptyline and selective serotonin reuptake inhibitors have been used to treat this symptom and they are effective to some degree within a short time window.[1][9]
- Anti-convulsants reduce neuronal hyperexcitability, effectively targeting Dejerine–Roussy syndrome. Gabapentin and pregabalin are the most common anti-convulsants. They have significant efficacy in treatment of peripheral and central neuropathic pain. Treatments last 4–12 hours and in general are well tolerated, and the occurrence of adverse events does not differ significantly across patients. Commonly reported side-effects are dizziness, decreased intellectual performance, somnolence, and nausea.[1]
- Topical treatment such as lidocaine patches can be used to treat pain locally.
Stimulation treatments
- Electrode stimulation from surgically implanted Electric stimulation utilizing implants deliver specific voltages to a specific part of the brain for specific durations. More recently, research is being done in radiation therapy as long-term treatment of Dejerine–Roussy syndrome. In general, these studies have concluded initial efficacy in such implants, but pain often re-appears after a year or so. Long-term efficacy of stimulation treatments must be further tested and evaluated.[10]
Expensive and invasive, the above treatments are not guaranteed to work, and are not meeting the needs of patients. There is a need for a new, less expensive, less invasive form of treatment, two of which are postulated below.[citation needed]
- Spinal cord stimulation has been studied in the last couple of years. In a long case study, 8 patients were given spinal cord stimulation via insertion of a thoracic spine. Between 36 and 149 months after the stimulations, the patients were interviewed. 6 of the 8 had received initial pain relief, and three experienced long-term pain relief. Spinal cord stimulation is cheaper than brain stimulation and less invasive, and is thus a more promising option for pain treatment.[11]
Epidemiology
8% of all stroke patients will experience central pain syndrome, with 5% experiencing moderate to severe pain. The risk of developing Dejerine–Roussy syndrome is higher in older stroke patients, about 11% of stroke patients over the age of 80.[1]
History
In 1906,
In 1911, it was found that the patients often developed pain and hypersensitivity to stimuli during recovery of function. And thus it was thought that the pain associated after stroke was part of the stroke and lesion repair process occurring in the brain.[medical citation needed] It is now accepted that Dejerine–Roussy syndrome is a condition developed due to lesions interfering with the sensory process, which triggered the start of pharmaceutical and stimulation treatment research. The last 50 years have been filled with refractory treatment research. As of the early 2000s, longer treatments lasting months to years have been explored in the continued search for permanent removal of abnormal pain.[1]
Eponym
Dejerine–Roussy syndrome has also been referred to as: "Posterior Thalamic Syndrome", "Retrolenticular Syndrome", "Thalamic Hyperesthetic Anesthesia", "Thalamic Pain Syndrome", "Thalamic Syndrome", "Central Pain Syndrome", and "Central Post-Stroke Syndrome".
See also
References
- ^ S2CID 7838197.)
{{cite journal}}
: CS1 maint: multiple names: authors list (link - .
- PMID 19005061.)
{{cite journal}}
: CS1 maint: multiple names: authors list (link - ^ PMID 20660417.)
{{cite journal}}
: CS1 maint: multiple names: authors list (link - ^ PMID 16275597.
- ^ "IASP pain terminology". wayback machine internet archive. Archived from the original on 12 May 2008. Retrieved 29 January 2020.
- PMID 18848810.)
{{cite journal}}
: CS1 maint: multiple names: authors list (link - ^ "Hydromorphone Monograph". Archived from the original on 2008-02-13. Retrieved 2013-02-06.
- PMID 21574822.)
{{cite journal}}
: CS1 maint: multiple names: authors list (link - PMID 17570607.)
{{cite journal}}
: CS1 maint: multiple names: authors list (link - S2CID 35575713.)
{{cite journal}}
: CS1 maint: multiple names: authors list (link - ^ "Pain: Hope Through Research". National Institute of Neurological Disorders and Stroke. 2011. Archived from the original on 2016-12-15. Retrieved 2011-11-21.
- ^ "Thalamic Syndrome (Dejerine Roussy)". National Organization for Rare Disorders. 2003.
- S2CID 40475515.)
{{cite journal}}
: CS1 maint: multiple names: authors list (link - S2CID 13141793.)
{{cite journal}}
: CS1 maint: multiple names: authors list (link - S2CID 13390074.)
{{cite journal}}
: CS1 maint: multiple names: authors list (link